FDA should 'under no circumstances' fast-track a COVID-19 vaccine, says patient safety group
The US Food and Drug Administration should not approve a vaccine before full clinical trials are completed, said ECRI, a nonprofit patient safety organization.

Full story is loading. Click here if it doesn't...

Advertisement